文献速递神经肿瘤

聚焦超声治疗脑转移瘤:全球临床试验进展

Focused ultrasound for brain metastases: an update on global clinical trials.
PubMed 文献 · J Neurooncol · 2023-11-01

本文综述了聚焦超声(FUS)在脑转移瘤治疗中的临床应用,检索了PubMed、Google Scholar和ClinicalTrials.gov相关临床试验。FUS可安全有效地开放血脑屏障、增强药物递送、辅助液体活检及声动力治疗,但尚需进一步研究以确立其标准治疗地位。

要点

  • FUS可安全有效地治疗原发性或转移性脑肿瘤。
  • FUS增强药物递送可开放血脑屏障,促进化疗、免疫及靶向药物转运。
  • FUS联合液体活检在早期检测、基因分型和个体化治疗方面有潜力。

核心结论

  • 需进一步研究以确立FUS作为脑转移瘤的标准治疗。
  • FUS有潜力改变脑肿瘤治疗格局,尤其与免疫治疗和靶向治疗联合时,可作为手术和放疗的非侵入性替代方案。

研究设计与样本

  • 综述通过PubMed、Google Scholar和ClinicalTrials.gov检索聚焦超声用于颅内转移瘤、胶质瘤或胶质母细胞瘤治疗的临床试验文献。

主要发现

  • FUS对原发性或转移性脑肿瘤的治疗安全有效。
  • FUS增强的药物递送可开放血脑屏障,促进化疗药物、免疫治疗和靶向治疗的转运。
  • FUS与液体活检整合在早期肿瘤检测、精确基因分型和个体化治疗方面具有显著潜力。
  • 声动力治疗可诱导肿瘤细胞凋亡,并可能用于增强手术和化疗等其他肿瘤治疗的效果。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需进一步研究以确立FUS作为脑转移瘤的标准治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite advances in immunotherapy and targeted treatments for malignancies of the central nervous system (CNS), the treatment of brain metastases (BMs) remains a formidable challenge, due largely to difficulties in crossing the blood-brain barrier (BBB), drug resistance, and molecular discrepancies. Focused ultrasound (FUS) is a non-invasive tool for BBB breaching, tumor ablation, enhancing drug delivery, promoting the release of tumor biomarkers for liquid biopsy, or the tumor microenvironment disruption. This paper presents a comprehensive review of the current literature related to FUS and its application in the treatment of brain metastasis. METHODS: This review of the current literature via PubMed, Google Scholar, and Clincaltrials.gov focused on clinical trials in which FUS is used in the intracranial treatment of metastatic tumor, glioma, or GBM. RESULTS: FUS is safe and effective for treatment of primary or metastatic brain tumors. FUS-augmented drug delivery can open BBB to facilitate the transport of chemotherapeutic agents, immunotherapies, and targeted treatments. The integration of FUS with liquid biopsy has considerable potential for early tumor detection, precise gene profiling, and personalized therapy. Sonodynamic therapy can induce tumor cell apoptosis and could potentially be used to enhance the outcomes of other tumor treatments, such as surgery and chemotherapy. CONCLUSION: Further work is required to establish FUS as a standard therapy for BMs. FUS has the potential to transform brain tumor treatment, particularly when combined with immunotherapy and targeted therapy as a non-invasive alternative to surgery and radiation therapy.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Chen YH, Moore D, Lee CC, et al. Focused ultrasound for brain metastases: an update on global clinical trials. J Neurooncol. 2023. PMID: 37910281. doi:10.1007/s11060-023-04492-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。